Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chronic obstructive pulmonary disease. Mortality and mortality reduction

S B Fiel1

  • 1Pulmonary and Critical Care Medicine, Medical College of Pennsylvania and Hahnemann University School of Medicine, Philadelphia, USA.

Drugs
|January 1, 1996
PubMed
Summary

Smoking cessation is the most crucial intervention for chronic obstructive pulmonary disease (COPD), a major global health issue. Future initiatives should prioritize this to control COPD effectively.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

History and evolution of aerosolized therapeutics: overview and introduction.

Chest·2001
Same author

Tobramycin solution for inhalation reduces sputum Pseudomonas aeruginosa density in bronchiectasis.

American journal of respiratory and critical care medicine·2000
Same author

Effect of smaller droplet size of dornase alfa on lung function in mild cystic fibrosis. Dornase Alfa Nebulizer Group.

Pediatric pulmonology·1998
Same author

Cystic fibrosis.

Current opinion in pulmonary medicine·1997
Same author

High-resolution CT in the acute exacerbation of cystic fibrosis: evaluation of acute findings, reversibility of those findings, and clinical correlation.

AJR. American journal of roentgenology·1997
Same author

Pregnancy in patients with cystic fibrosis.

Pediatric pulmonology. Supplement·1997

Area of Science:

  • Pulmonology
  • Public Health

Background:

  • Chronic obstructive pulmonary disease (COPD) impacts millions globally and is a leading cause of death.
  • Current COPD treatments have seen minimal advancement over decades, despite increased disease understanding.
  • Smoking is the primary risk factor, responsible for approximately 90% of COPD cases.

Purpose of the Study:

  • To review the current landscape of COPD management.
  • To emphasize the critical role of smoking cessation in COPD intervention.
  • To discuss the limitations of existing and emerging pharmacotherapeutic options.

Main Methods:

  • Literature review of COPD epidemiology, risk factors, and treatment modalities.
  • Analysis of the efficacy of current pharmacotherapies and recent investigational agents.

Related Experiment Videos

  • Evaluation of the significance of smoking cessation as a primary intervention.

    • Main Results:

    • Smoking cessation remains the most effective intervention for managing COPD.
    • Pharmacotherapeutic options like corticosteroids, bronchodilators, and antibiotics address symptoms and exacerbations but do not alter disease progression significantly.
    • Investigational treatments, such as dornase alfa for exacerbations, have shown disappointing results without mortality benefits.

    Conclusions:

    • Smoking cessation is paramount for controlling COPD and should be the focus of public health initiatives.
    • While research continues to explore new treatments, optimizing existing therapies and reinforcing smoking cessation are key.
    • Effective COPD management hinges on addressing the root cause—smoking—and supporting cessation efforts.